These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20156103)

  • 1. Comparison of genotypic resistance mutations in treatment-naive HIV type 1-infected patients in Korea and China.
    Chin BS; Choi JY; Han Y; Kuang J; Li Y; Han SH; Choi H; Chae YT; Jin SJ; Baek JH; Lim YS; Kim CO; Song YG; Yong D; Li T; Kim JM
    AIDS Res Hum Retroviruses; 2010 Feb; 26(2):217-21. PubMed ID: 20156103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance.
    Kousiappa I; van de Vijver DA; Demetriades I; Kostrikis LG
    AIDS Res Hum Retroviruses; 2009 Jan; 25(1):23-35. PubMed ID: 19182918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profile of HIV type 1 infection and genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV type 1-infected individuals in Hai Phong, Viet Nam.
    Ishizaki A; Cuong NH; Thuc PV; Trung NV; Saijoh K; Kageyama S; Ishigaki K; Tanuma J; Oka S; Ichimura H
    AIDS Res Hum Retroviruses; 2009 Feb; 25(2):175-82. PubMed ID: 19239356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
    Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
    Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment Naïve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia.
    Ong LY; Razak SN; Lee YM; Sri La Sri Ponnampalavanar S; Syed Omar SF; Azwa RI; Tee KK; Kamarulzaman A
    J Med Virol; 2014 Jan; 86(1):38-44. PubMed ID: 24127302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso.
    Tebit DM; Sangaré L; Tiba F; Saydou Y; Makamtse A; Somlare H; Bado G; Kouldiaty BG; Zabsonre I; Yameogo SL; Sathiandee K; Drabo JY; Kräusslich HG
    J Med Virol; 2009 Oct; 81(10):1691-701. PubMed ID: 19697403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012.
    Yang WL; Kouyos R; Scherrer AU; Böni J; Shah C; Yerly S; Klimkait T; Aubert V; Furrer H; Battegay M; Cavassini M; Bernasconi E; Vernazza P; Held L; Ledergerber B; Günthard HF;
    J Infect Dis; 2015 Jul; 212(1):28-38. PubMed ID: 25576600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 transmitted drug resistance and genetic diversity among patients from Piauí State, Northeast Brazil.
    Moura ME; da Guarda Reis MN; Lima YA; Eulálio KD; Cardoso LP; Stefani MM
    J Med Virol; 2015 May; 87(5):798-806. PubMed ID: 25649362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, virological and phylogenetic characterization of a multiresistant HIV-1 strain outbreak in naive patients in southern Spain.
    Viciana I; González-Domenech CM; Palacios R; Delgado M; Del Arco A; Tellez F; Jarilla F; Fernández S; Clavijo E; Santos J
    J Antimicrob Chemother; 2016 Feb; 71(2):357-61. PubMed ID: 26483513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of transmitted HIV type 1 drug resistance in newly diagnosed hiv type 1-infected patients in Shandong Province, China.
    Zhang J; Kang D; Fu J; Sun X; Lin B; Bi Z; Nkengasong JN; Yang C
    AIDS Res Hum Retroviruses; 2010 Jan; 26(1):99-103. PubMed ID: 20121622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of HIV type 1 genotypes and drug resistance mutations among drug-naive HIV type 1-infected patients in Northern Vietnam.
    Phan TT; Ishizaki A; Phung DC; Bi X; Oka S; Ichimura H
    AIDS Res Hum Retroviruses; 2010 Feb; 26(2):233-5. PubMed ID: 20156106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America.
    Holguín Á; Yebra G; Martín L; de Pineda AT; Ruiz LE; Quezada AY; Nieto AI; Escobar G
    Clin Microbiol Infect; 2013 Dec; 19(12):E523-32. PubMed ID: 23782115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appearance of drug resistance-associated mutations in human immunodeficiency virus type 1 protease and reverse transcriptase derived from drug-treated Indonesian patients.
    Khairunisa SQ; Kotaki T; Witaningrum AM; Yunifiar M MQ; Sukartiningrum SD; Nasronudin ; Kameoka M
    AIDS Res Hum Retroviruses; 2015 Feb; 31(2):255-9. PubMed ID: 25348045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmitted HIV type 1 drug resistance in newly diagnosed Cuban patients.
    Machado LY; Dubed M; Díaz H; Ruiz N; Romay D; Váldes N; Blanco M; Silva E
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):411-4. PubMed ID: 22985307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of distinct human immunodeficiency virus type 1 circulating recombinant forms in northeast Brazil.
    Santos LA; Monteiro-Cunha JP; Araujo AF; Brites C; Galvao-Castro B; Alcantara LC
    J Med Virol; 2011 Dec; 83(12):2066-72. PubMed ID: 22012712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short Communication: Increase of HIV-1 K103N Transmitted Drug Resistance and Its Association with Efavirenz Use in South Korea.
    Chin BS; Shin HS; Kim G; Wagner GA; Gianella S; Smith DM
    AIDS Res Hum Retroviruses; 2015 Jun; 31(6):603-7. PubMed ID: 25826122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of genotypic drug resistance and presence of several naturally occurring polymorphisms of human immunodeficiency virus-1 CRF06_cpx in treatment-naive patients in Estonia.
    Avi R; Huik K; Sadam M; Karki T; Krispin T; Ainsalu K; Paap P; Schmidt J; Nikitina N; Lutsar I
    J Med Virol; 2009 Jun; 81(6):953-8. PubMed ID: 19382254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence and determinants of drug-resistance-associated mutations in the HIV-1-infected MSM population of Henan Province in China.
    Hou LJ; Wang HW; Duan SP; Zhuo Y; Zhou YC; Wu HJ; Shen BS
    Arch Virol; 2015 Aug; 160(8):2051-61. PubMed ID: 26077516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation of the HIV-1 integrase region in newly diagnosed anti-retroviral drug-naïve patients with HIV/AIDS in Korea.
    Kim JY; Kim EJ; Choi JY; Kwon OK; Kim GJ; Choi SY; Kim SS
    Clin Microbiol Infect; 2011 Aug; 17(8):1155-9. PubMed ID: 20946407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and epidemiological characterization of HIV-1 infection networks involving transmitted drug resistance mutations in Northern Greece.
    Skoura L; Metallidis S; Buckton AJ; Mbisa JL; Pilalas D; Papadimitriou E; Papoutsi A; Haidich AB; Chrysanthidis T; Tsachouridou O; Antoniadou ZA; Kollaras P; Nikolaidis P; Malisiovas N
    J Antimicrob Chemother; 2011 Dec; 66(12):2831-7. PubMed ID: 21933785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.